Population Pharmacokinetic Analysis for Imipenem–Relebactam in Healthy Volunteers and Patients With Bacterial Infections

Relebactam is a small‐molecule β‐lactamase inhibitor developed as a fixed‐dose combination with imipenem/cilastatin. The pharmacokinetics of relebactam and imipenem across 10 clinical studies were analyzed using data from adult healthy volunteers and patients with bacterial infections. Renal functio...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhagunde, Pratik, Patel, Parul, Lala, Mallika, Watson, Kenny, Copalu, William, Xu, Ming, Kulkarni, Pooja, Young, Katherine, Rizk, Matthew L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6813166/
https://www.ncbi.nlm.nih.gov/pubmed/31508899
http://dx.doi.org/10.1002/psp4.12462

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6813166/
https://www.ncbi.nlm.nih.gov/pubmed/31508899
http://dx.doi.org/10.1002/psp4.12462

Ejemplares similares